These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9798074)

  • 1. The effects of chlorpromazine and lorazepam on abnormal antisaccade and no-saccade distractibility.
    Green JF; King DJ
    Biol Psychiatry; 1998 Oct; 44(8):709-15. PubMed ID: 9798074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam.
    Green JF; King DJ; Trimble KM
    J Psychopharmacol; 2000 Mar; 14(1):30-6. PubMed ID: 10757250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers.
    McCartan D; Bell R; Green JF; Campbell C; Trimble K; Pickering A; King DJ
    J Psychopharmacol; 2001 Jun; 15(2):96-104. PubMed ID: 11448094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam.
    Green JF; McElholm A; King DJ
    Psychopharmacology (Berl); 1996 Nov; 128(1):67-73. PubMed ID: 8944408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lorazepam on saccadic eye movements: the role of sex, task characteristics and baseline traits.
    Ettinger U; Meyhöfer I; Mehta MA; Kumari V; Corr PJ; Williams SC; Perkins AM
    J Psychopharmacol; 2018 Jun; 32(6):678-690. PubMed ID: 29783905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
    de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
    J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia.
    Karpouzian-Rogers T; Stocks J; Meltzer HY; Reilly JL
    Schizophr Res; 2020 Jan; 215():314-321. PubMed ID: 31706786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography study of voluntary saccadic eye movements and spatial working memory.
    Sweeney JA; Mintun MA; Kwee S; Wiseman MB; Brown DL; Rosenberg DR; Carl JR
    J Neurophysiol; 1996 Jan; 75(1):454-68. PubMed ID: 8822570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine-induced distractibility: An oculomotor study in monkeys.
    Condy C; Wattiez N; Rivaud-Péchoux S; Gaymard B
    Biol Psychiatry; 2005 Feb; 57(4):366-72. PubMed ID: 15705352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
    de Haas SL; de Visser SJ; van der Post JP; Schoemaker RC; van Dyck K; Murphy MG; de Smet M; Vessey LK; Ramakrishnan R; Xue L; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Jan; 22(1):24-32. PubMed ID: 18187530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction.
    Thaker GK; Nguyen JA; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):49-59. PubMed ID: 2563231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of haloperidol on visual search, eye movements and psychomotor performance.
    Lynch G; King DJ; Green JF; Byth W; Wilson-Davis K
    Psychopharmacology (Berl); 1997 Oct; 133(3):233-9. PubMed ID: 9361328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lorazepam on saccadic eye movements - evidence from prosaccade and free viewing tasks.
    Baumert PM; Faßbender K; Wintergerst MWM; Terheyden JH; Aslan B; Foulsham T; Harmening W; Ettinger U
    Psychopharmacology (Berl); 2024 Sep; ():. PubMed ID: 39225714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lorazepam on prosaccades and saccadic adaptation.
    Bey K; Lippold JV; Aslan B; Hurlemann R; Ettinger U
    J Psychopharmacol; 2021 Jan; 35(1):91-99. PubMed ID: 33274663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor antisaccade performance in schizophrenia: an inhibition deficit?
    Reuter B; Rakusan L; Kathmanna N
    Psychiatry Res; 2005 May; 135(1):1-10. PubMed ID: 15893384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saccadic distractibility in first-episode schizophrenia.
    Hutton SB; Joyce EM; Barnes TR; Kennard C
    Neuropsychologia; 2002; 40(10):1729-36. PubMed ID: 11992660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.
    Hindmarch I; Gudgeon AC
    Br J Clin Pharmacol; 1980 Aug; 10(2):145-50. PubMed ID: 6107116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population.
    van Steveninck AL; Wallnöfer AE; Schoemaker RC; Pieters MS; Danhof M; van Gerven JM; Cohen AF
    Br J Clin Pharmacol; 1997 Sep; 44(3):267-75. PubMed ID: 9296321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccadic disinhibition in schizophrenia patients and their first-degree biological relatives. A parametric study of the effects of increasing inhibitory load.
    Curtis CE; Calkins ME; Iacono WG
    Exp Brain Res; 2001 Mar; 137(2):228-36. PubMed ID: 11315552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.